Pharmaceuticals & Biotechnology

Pharmaceuticals & Biotechnology

Recent Posts

Michael Leuchten

Michael Leuchten joined Jefferies in June 2025 to lead the European Pharmaceuticals & Biotechnology team. He has over 20 years of experience covering Pharma & Biotech on both the sell- and buy-side, with a more specific focus on European Large-Cap Pharma. Lucy Codrington joined Jefferies in January 2016 and has been covering the Healthcare sector

Shan Hama

Shan Hama joined the team as a graduate in September 2023, recently ramping up coverage in European Small-Mid Cap Biotechnology and Biopharmaceuticals, also providing support to the rest of the team. Michael Leuchten joined Jefferies in June 2025 to lead the European Pharmaceuticals & Biotechnology team. He has over 20 years of experience covering Pharma

Benjamin Jackson

Benjamin Jackson joined Jefferies in January 2023, primarily aiding European Large-Cap Pharma research, but also working on his own coverage in European Small-Mid Cap Biopharmaceuticals. Michael Leuchten joined Jefferies in June 2025 to lead the European Pharmaceuticals & Biotechnology team. He has over 20 years of experience covering Pharma & Biotech on both the sell-

Jan Scherer

Jan Scherer is a specialist salesperson covering the global healthcare sector. He has been covering the sector for 19 years, on the sellside at Jefferies and UBS, and in the buyside at UBS, running a range of healthcare equity strategies.

Lucy Codrington

Lucy Codrington joined Jefferies in January 2016 and has been covering the Healthcare sector for almost a decade, with expertise in European Small-Mid Cap Biotechnology and Biopharmaceuticals. Michael Leuchten joined Jefferies in June 2025 to lead the European Pharmaceuticals & Biotechnology team. He has over 20 years of experience covering Pharma & Biotech on both